Search

everythinglearnresearchcommunity

for

Search:↓

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Delonix polymeric nanoparticles with isotretinoin effectively treat acne by targeting hair follicles and reducing skin irritation.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Combining soursop leaf extract with doxorubicin may improve breast cancer treatment and reduce side effects.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Ruxolitinib treatment may cause eyelash growth.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Alpha-tocopherol does not prevent hair loss from doxorubicin.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Stopping isoniazid can reverse hair loss caused by the drug.

Targeting lipid metabolism can help treat advanced, resistant cancers.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Blocking CISD1 reduces hearing loss from cisplatin in mice.

Vorasidenib can cause unusual hair growth.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Repurposing existing drugs can improve cancer treatment but faces challenges.

Chemotherapy can cause permanent hair loss.

Temozolomide can cause severe bone marrow suppression, leading to life-threatening complications.

Alkylating agents can kill cancer cells but may cause skin and allergic reactions.